{"id":"https://genegraph.clinicalgenome.org/r/25eca37c-278f-4885-8ee3-21814f614f7fv1.1","type":"EvidenceStrengthAssertion","dc:description":"*PIGL* is involved in the biosynthesis of glycosylphosphatidylinositol (GPI), which is required to anchor proteins to the cell membrane. Variants in *PIGL* have been reported in patients with autosomal recessive syndromic intellectual disability, including CHIME syndrome (colobomas, heart defects, ichthyosiform dermatosis, intellectual disability, and ear abnormalities) and Mabry syndrome (hyperphosphatasia intellectual disability syndrome). *PIGL* was first reported in relation to CHIME syndrome in 2012 (Ng et al., PMID: 22444671). Five unrelated probands with CHIME syndrome had compound heterozygous variants in *PIGL*; they all shared the same p.Leu167Pro missense variant and had different null variants in the second allele .\n Variants in this gene have been reported in at least 12 probands in 8 publications (PMIDs: 22444671, 25706356, 28327575, 28371479, 29444765, 29473937, 30023290, 35258128), including 11 missense (p.Leu167Pro recurrent 8 times), 3 frameshift, 3 nonsense, 2 splice-site, and 3 partial or whole gene deletions . Affected individuals had CHIME syndrome, Mabry syndrome, overlapping features of both syndromes, or intellectual disability with dysmorphic features and seizures. Of note, all individuals with CHIME syndrome reported thus far carried the recurrent p.Leu167Pro variant. \nThis gene-disease relationship is also supported by protein interaction with MEIS2 (PMID: 26186194), biochemical function (PMID: 10085243) and functional alteration in patient cells (PMID: 22444671).\nIn summary, there is definitive evidence supporting the relationship between *PIGL* and autosomal recessive syndromic intellectual disability. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on December 7, 2022 (SOP Version 9).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/25eca37c-278f-4885-8ee3-21814f614f7f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/7c33f1e7-bad5-4f88-93e8-02d21e7e1850","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/7c33f1e7-bad5-4f88-93e8-02d21e7e1850_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2022-12-07T19:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/7c33f1e7-bad5-4f88-93e8-02d21e7e1850_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2023-04-04T19:49:15.165Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c33f1e7-bad5-4f88-93e8-02d21e7e1850_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c33f1e7-bad5-4f88-93e8-02d21e7e1850_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1861a0b6-9d56-4216-919c-02fcfe35ed16","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c904ef54-99fe-4740-82f3-62d06a4d3836","type":"Finding","dc:description":"interaction with MEIS2, which is implicated in Cleft palate, cardiac defects, and mental retardation (OMIM 600987)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26186194","rdfs:label":"PIGL and MEIS2 interaction ","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/635e24ea-74a8-4ba5-9925-fca8cecee5ec","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e995479-22d1-4ffc-bbc5-fca90b882150","type":"Finding","dc:description":"Glycosylphosphatidylinositol biosynthesis defects cause rare genetic disorders characterised by developmental delay/intellectual disability, seizures, dysmorphic features, and diverse congenital anomalies associated with a wide range of additional features.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10085243","rdfs:label":"recombinant rat PIG-L protein involved in GPI biosynthesis","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7c33f1e7-bad5-4f88-93e8-02d21e7e1850_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8df6b4cd-9057-4197-9764-33e8db1b3ce0","type":"EvidenceLine","dc:description":"Only fluorescence-activated cell sorting analysis for two separate GPI anchor markers, CD59 and FLAER","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/517f3931-d730-4f7c-8554-26d5e4a18aab","type":"FunctionalAlteration","dc:description":"Increased Cell Surface Expression of Total GPI Anchor and CD59 Fluorescence-activated cell sorting analysis for two separate GPI anchor markers, CD59 and FLAER in a primary fibroblast line from individual 3988. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","rdfs:label":"GPI marker in primary fibroblasts from individual 3988 "}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7c33f1e7-bad5-4f88-93e8-02d21e7e1850_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67c3c706-2ab5-4049-9493-ac28e5d80e36_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67c3c706-2ab5-4049-9493-ac28e5d80e36","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25706356","rdfs:label":"Fujiwara Proband 1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/fdc8e002-14f6-4248-ad74-9ed86a3f2958","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.38_50del (p.Val13AlafsTer12)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573332393"}},{"id":"https://genegraph.clinicalgenome.org/r/9060de9b-25bb-406b-a48e-c0f5b7bfae80","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.258_259del (p.Glu86AspfsTer3)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8409808"}}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"A patient with severe intellectual disability, distinctive facial appearance, fragile nails, and persistent increased serum levels of alkaline phosphatase (ALP)\nThe patient did not have colobomas, congenital heart defects, or early onset migratory ichthyosiform dermatosis and hence was diagnosed with Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS)\n","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ed87ee37-bba0-4133-98d7-c5c5d23ed6d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25706356","allele":{"id":"https://genegraph.clinicalgenome.org/r/9060de9b-25bb-406b-a48e-c0f5b7bfae80"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/4cacea35-8b5b-4fa5-8ae7-546bc79419c4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25706356","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdc8e002-14f6-4248-ad74-9ed86a3f2958"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/4cacea35-8b5b-4fa5-8ae7-546bc79419c4","type":"EvidenceLine","dc:description":"Maximum 2 points allocated to a proband with a recessive disorder as per GCEP.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4cacea35-8b5b-4fa5-8ae7-546bc79419c4_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ed87ee37-bba0-4133-98d7-c5c5d23ed6d2","type":"EvidenceLine","dc:description":"Maximum 2 points allocated to a proband with a recessive disorder as per GCEP.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed87ee37-bba0-4133-98d7-c5c5d23ed6d2_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/be633033-b715-4095-a433-7a875ccdcb99_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be633033-b715-4095-a433-7a875ccdcb99","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29473937","rdfs:label":"Ceroni Proband 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.500T>C (p.Leu167Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129322"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Developmental milestones were delayed.\nEpilepsy, with a first seizure at 8 months of age during a febrile episode. \nPhysical examination weight,  height and OFC all > 95%\nfine hair, prominent forehead, ocular hypertelorism, upslanting palpebral fissures, everted lower lip, small, widely-spaced teeth, with fusion of the central and lateral right incisors, and uplifted ear lobes; short neck; large hands, with brachydactyly, finger pads and incomplete single palmar creases; \nhyperchromic/ichthyosiform skin lesions in neck, axillas and knees, geographic lesions with hyperpigmented borders in the thorax and abdominal areas and palmar hyperkeratosis. \n\nnormal echocardiography and cranial CT scan; hand X-rays with short distal phalanges of all fingers, as well, as the medial phalanx of the left fifth digit,\nand advanced bone age;\n\nophthalmologic evaluation, bilateral retinal coloboma;\n renal ultrasound, bilateral pyelocaliceal ectasia\n\n\n","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d188ed95-e7f3-4d9e-aff9-83a630969b47_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29473937","allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}},{"id":"https://genegraph.clinicalgenome.org/r/d188ed95-e7f3-4d9e-aff9-83a630969b47","type":"EvidenceLine","dc:description":"recurrent pathogenic variant;\nsecond variant is a large deletion involving the 5’ untranslated region and part of exon 1 of PIGL.(chr7: 16,119,889-16,120,690)\n\n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d188ed95-e7f3-4d9e-aff9-83a630969b47_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a7d78103-4063-4427-a9d9-6fa59a7c826c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7d78103-4063-4427-a9d9-6fa59a7c826c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","rdfs:label":"33300","ageType":"AgeAtReport","ageUnit":"Months","ageValue":21,"allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},"firstTestingMethod":"Exome sequencing","secondTestingMethod":"Chromosomal microarray","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b6671cd3-4b7b-489a-90ec-9a9b2c52d27b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}},{"id":"https://genegraph.clinicalgenome.org/r/b6671cd3-4b7b-489a-90ec-9a9b2c52d27b","type":"EvidenceLine","dc:description":"The second mutation in this proband is a 1 Mb deletion in chromosome 17, involving PIGL and other genes.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6671cd3-4b7b-489a-90ec-9a9b2c52d27b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b6671cd3-4b7b-489a-90ec-9a9b2c52d27b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"EBV-transformed lymphoblast cell line show deficient in two separate cell surface GPI-anchor-containing markers, CD59 and a GPI-binding toxin, aerolysin (FLAER)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bbd43fc0-3cda-452d-a60b-2d5e5ae201b5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bbd43fc0-3cda-452d-a60b-2d5e5ae201b5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","rdfs:label":"682-2-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":15,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},{"id":"https://genegraph.clinicalgenome.org/r/7890f525-fd33-4ae2-8dc1-a8f94176eb3b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.652C>T (p.Gln218Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129323"}}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Craniofacial dysmorphic features, cardiac anomaly(TGA), Developmental delay/Intellectual disability, seizures, Wide based gait, Icthyosiform rash, Thick palms/soles","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/32293f47-2f1a-423f-b4e8-915ce9b8d2d6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/f4d4c04c-607c-4e93-90a9-5a56d41e29a6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","allele":{"id":"https://genegraph.clinicalgenome.org/r/7890f525-fd33-4ae2-8dc1-a8f94176eb3b"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/f4d4c04c-607c-4e93-90a9-5a56d41e29a6","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4d4c04c-607c-4e93-90a9-5a56d41e29a6_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/32293f47-2f1a-423f-b4e8-915ce9b8d2d6","type":"EvidenceLine","dc:description":"recurrent pathogenic variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32293f47-2f1a-423f-b4e8-915ce9b8d2d6_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/71ee2a40-72e1-4fe9-8190-c8603408aa1b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71ee2a40-72e1-4fe9-8190-c8603408aa1b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","rdfs:label":"680-2-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/1bfe9300-a14b-4a5b-a717-22bded62c164","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.274del (p.Leu92PhefsTer15)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8409814"}},{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Craniofacial dysmorphic features, Developmental delay/Intellectual disability, seizures, Wide based gait, Cerebral atrophy, Icthyosiform rash, Thick palms/soles","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/39d7bfc4-5796-49fa-869e-feb855deed4f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/3faddf04-92da-444b-8856-a130d50438ed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","allele":{"id":"https://genegraph.clinicalgenome.org/r/1bfe9300-a14b-4a5b-a717-22bded62c164"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/3faddf04-92da-444b-8856-a130d50438ed","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3faddf04-92da-444b-8856-a130d50438ed_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/39d7bfc4-5796-49fa-869e-feb855deed4f","type":"EvidenceLine","dc:description":"recurrent pathogenic variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39d7bfc4-5796-49fa-869e-feb855deed4f_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/ba66badd-2eb7-4763-b627-536dea1ed4ea_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba66badd-2eb7-4763-b627-536dea1ed4ea","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28327575","rdfs:label":"Decipher-277013","allele":[{"id":"https://genegraph.clinicalgenome.org/r/295605f9-21ef-43e0-a112-029e213cebd6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.48G>A (p.Trp16Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8409740"}},{"id":"https://genegraph.clinicalgenome.org/r/36571375-806a-4d87-a287-7ce6d91e98e6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.336-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8409873"}}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Moderate global developmental delay, renal cysts, cutis marmorata, broad hallux, pectus excavatum, wide mouth; seizure\n","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8148d646-d490-43b4-a7fd-06e3350c022a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28327575","allele":{"id":"https://genegraph.clinicalgenome.org/r/295605f9-21ef-43e0-a112-029e213cebd6"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/a5afa564-93aa-4b19-a5db-10e10e717c7d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28327575","allele":{"id":"https://genegraph.clinicalgenome.org/r/36571375-806a-4d87-a287-7ce6d91e98e6"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/8148d646-d490-43b4-a7fd-06e3350c022a","type":"EvidenceLine","dc:description":"Maximum 2 points allocated to a proband with a recessive disorder as per GCEP.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8148d646-d490-43b4-a7fd-06e3350c022a_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a5afa564-93aa-4b19-a5db-10e10e717c7d","type":"EvidenceLine","dc:description":"Maximum 2 points allocated to a proband with a recessive disorder as per GCEP.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5afa564-93aa-4b19-a5db-10e10e717c7d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fd8d0d76-d4f1-4a71-82e2-fd8d43b7451e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd8d0d76-d4f1-4a71-82e2-fd8d43b7451e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","rdfs:label":"665-3-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Transient tachycardia, transient hypoglicemia,  Craniofacial dysmorphic features, Developmental delay/Intellectual disability, seizure, cerebral atrophy, hydronephrosis, Icthyosiform rash, mildly elevated alkaline phosphatase (ALP) serum level ","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9b82bc78-53eb-488d-a2ec-003f5e0fd4ab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}},{"id":"https://genegraph.clinicalgenome.org/r/9b82bc78-53eb-488d-a2ec-003f5e0fd4ab","type":"EvidenceLine","dc:description":"second mutation not identified; parent DNA unavailable","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b82bc78-53eb-488d-a2ec-003f5e0fd4ab_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/67cc40aa-c355-491a-b342-11323116ea1a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67cc40aa-c355-491a-b342-11323116ea1a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29444765","rdfs:label":"Mogami Proband 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/7c25c40a-010d-4454-8efb-221e4e24989e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.701G>A (p.Arg234His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA288216359"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"The phenotypes of the subjects were not consistent with CHIME syndrome or Mabry syndrome, as reported in previous studies. All shared some clinical manifestations, including transient apnoea as neonates, dysmorphic facial features, and intellectual disability. Between one week and 3 months of life, all patients developed myoclonic seizures. Myoclonic jerks were easily evoked by sudden unexpected acoustic or tactile stimuli. None showed elevation of serum alkaline phosphatase. Vitamin B6 was given to one of the three siblings but failed to suppress seizures. ","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b724a4ed-842e-4e7a-acef-584aff3983b8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29444765","allele":{"id":"https://genegraph.clinicalgenome.org/r/7c25c40a-010d-4454-8efb-221e4e24989e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}},{"id":"https://genegraph.clinicalgenome.org/r/b724a4ed-842e-4e7a-acef-584aff3983b8","type":"EvidenceLine","dc:description":"missense variant was detected in the three siblings and their mother. \nUnclear second variant. The qPCR shows the level of expression of exon 3 in the three siblings and the father was half that of the mother, indicating that the children inherited a loss-of-function variant from the father that remains to be identified.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b724a4ed-842e-4e7a-acef-584aff3983b8_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/092395b3-6f68-4159-b784-f326420d9913_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/092395b3-6f68-4159-b784-f326420d9913","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30023290","rdfs:label":"Altassan Proband 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/d855d067-8920-4021-a5d2-d496f532d7ba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.60G>A (p.Trp20Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10588638"}},{"id":"https://genegraph.clinicalgenome.org/r/1af431db-51e8-4954-bda1-8a774f3727cf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.262C>T (p.Arg88Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16620334"}}],"detectionMethod":"multigene panel for intellectual disability (GeneDx) ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"main features of HPMRS; developmental delay, cognitive impairment, seizure disorder, skeletal deformities, and high alkaline phosphatase. ","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0b895887-cdaf-4257-a2f0-5236d00f9567_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30023290","allele":{"id":"https://genegraph.clinicalgenome.org/r/1af431db-51e8-4954-bda1-8a774f3727cf"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/bcd53556-ebbc-4355-8f5d-550cef39d434_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30023290","allele":{"id":"https://genegraph.clinicalgenome.org/r/d855d067-8920-4021-a5d2-d496f532d7ba"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/bcd53556-ebbc-4355-8f5d-550cef39d434","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bcd53556-ebbc-4355-8f5d-550cef39d434_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0b895887-cdaf-4257-a2f0-5236d00f9567","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b895887-cdaf-4257-a2f0-5236d00f9567_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/ce54a689-a94d-415c-be0c-a1784327f462_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce54a689-a94d-415c-be0c-a1784327f462","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28371479","rdfs:label":"Knight Johnson Proband 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prenatal ultrasound: cleft lip palate, Cardiac abnormalities (double outlet ventricule, peripheral pulmonic stenosis)\nTypical Craniofacial features for CHIME\nDevelopmental delay/Intellectual disability and Seizure\nSkin Icthyosiform rash\n","secondTestingMethod":"Chromosomal microarray","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6ddfcb02-d2a5-47ed-b94c-8c2cad7aa3d1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28371479","allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}},{"id":"https://genegraph.clinicalgenome.org/r/6ddfcb02-d2a5-47ed-b94c-8c2cad7aa3d1","type":"EvidenceLine","dc:description":"recurrent pathogenic variant; The second variant is a an intragenic deletion of PIGL’s exons 4-6 (c.426+6654_660+3131del)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ddfcb02-d2a5-47ed-b94c-8c2cad7aa3d1_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/579d6148-d2dd-4e8e-b796-7da57a4f55d3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/579d6148-d2dd-4e8e-b796-7da57a4f55d3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","rdfs:label":"3988","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/5e939773-51e4-47f8-abbe-2d9d68674308","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.427-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8409908"}},{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Retinal Coloboma, Flat/broad nasal root,  conductive deafness, Cardiac anomaly (subaortic stenosis), Developmental delay/Intellectual Disability, seizure, wide based gait,  Ichyosiform rash  ","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/2ef76e99-dc2b-42c9-b4fb-38de2ee7d9b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/ba4ac1b2-3d96-4d2f-b972-9cf3d0c8bdb2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22444671","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e939773-51e4-47f8-abbe-2d9d68674308"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/ba4ac1b2-3d96-4d2f-b972-9cf3d0c8bdb2","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba4ac1b2-3d96-4d2f-b972-9cf3d0c8bdb2_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2ef76e99-dc2b-42c9-b4fb-38de2ee7d9b3","type":"EvidenceLine","dc:description":"recurrent pathogenic variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ef76e99-dc2b-42c9-b4fb-38de2ee7d9b3_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/3b6da601-ac03-4669-b8e2-88956fa73595_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b6da601-ac03-4669-b8e2-88956fa73595","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35258128","rdfs:label":"Rolland Proband 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},{"id":"https://genegraph.clinicalgenome.org/r/d0f081ab-0543-4b79-a7d1-01f34207d38d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004278.4(PIGL):c.154G>A (p.Asp52Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA398469073"}}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"An initial delay in psychomotor development and skin abnormalities consistent with CHIME syndrome but with atypical clinical features and laboratory findings. \n\nClinical features of early-onset epilepsy, hair, tooth and nail abnormalities, and ichthyosiform dermatitis were consistent with a diagnosis of CHIME. Persistent, excessive growth has also been reported in two cases of CHIME syndrome \n\nAdditional Clinical features: Epileptic seizures, facial dysmorphism (including a prominent forehead, hypertelorism, and epicanthal folds), widely spaced teeth, and skin, hair and nail anomalies (such as sparse, thin hair, thick palms and soles, and migratory ichthyosis) \n","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/cc480240-3c3d-452a-8d24-5add45529010_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35258128","allele":{"id":"https://genegraph.clinicalgenome.org/r/d0f081ab-0543-4b79-a7d1-01f34207d38d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/abb09c00-9e69-4fc9-9d14-c40cc3391deb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35258128","allele":{"id":"https://genegraph.clinicalgenome.org/r/18bd1477-6a12-4e0a-8e50-4c41a8f16d0f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/abb09c00-9e69-4fc9-9d14-c40cc3391deb","type":"EvidenceLine","dc:description":"recurrent pathogenic variant ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/abb09c00-9e69-4fc9-9d14-c40cc3391deb_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cc480240-3c3d-452a-8d24-5add45529010","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc480240-3c3d-452a-8d24-5add45529010_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":6099,"specifiedBy":"GeneValidityCriteria9","strengthScore":13.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/eVVXTdKE9YM","type":"GeneValidityProposition","disease":"obo:MONDO_0000508","gene":"hgnc:8966","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_7c33f1e7-bad5-4f88-93e8-02d21e7e1850-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}